Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel entorhinal projection to the rat dentate gyrus: direct innervation of proximal dendrites and cell bodies of granule cells and GABAergic neurons.

The Journal of neuroscience : the official journal of the Society for Neuroscience·1996
Same author

Diagnostic utility of K-ras mutations in fine-needle aspirates of pancreatic masses.

Gastroenterology·1996
Same author

Mutational analysis and secondary structure model of the RNP1-like sequence motif of transcription termination factor Rho.

Journal of molecular biology·1996
Same author

Residues in the RNP1-like sequence motif of Rho protein are involved in RNA-binding affinity and discrimination.

Journal of molecular biology·1996
Same author

Effects of continuous low-dose-rate brachytherapy on the rectum of the rat.

Radiation research·1996
Same author

Efficacy of epiroprim (Ro11-8958), a new dihydrofolate reductase inhibitor, in the treatment of acute Toxoplasma infection in mice.

The American journal of tropical medicine and hygiene·1996
Same journal

[How I do… to see the sliding sign by transvaginal ultrasonography?]

Gynecologie, obstetrique & fertilite·2016
Same journal

[Cell-free fetal DNA screening tests for trisomy 21].

Gynecologie, obstetrique & fertilite·2016
Same journal

[Lucy's cancer(s): A prehistorical origin?]

Gynecologie, obstetrique & fertilite·2016
Same journal

[Male age in assisted reproductive technologies: Is there a limit?]

Gynecologie, obstetrique & fertilite·2016
Same journal

[Iodinated contrast in pregnant women and neonatal thyroid function].

Gynecologie, obstetrique & fertilite·2016
Same journal

[Breast cancer and diabetes mellitus: Complex interactions].

Gynecologie, obstetrique & fertilite·2016
See all related articles

Related Experiment Video

Updated: May 26, 2026

Laparoscopic Non-Mesh Cerclage Pectopexy with Uterine Preservation for Pelvic Organ Prolapse
03:30

Laparoscopic Non-Mesh Cerclage Pectopexy with Uterine Preservation for Pelvic Organ Prolapse

Published on: October 25, 2024

[Pelvic exenteration: current state and perspectives].

G Ferron1, C Pomel, A Martinez

  • 1Institut Claudius Regaud, departement de chirurgie oncologique, 20-24, rue du Pont-Saint-Pierre, 31052 Toulouse, France. ferron.gwenael@claudiusregaud.fr

Gynecologie, Obstetrique & Fertilite
|December 24, 2011
PubMed
Summary
This summary is machine-generated.

Patient selection for pelvic exenteration is evolving due to advances in cancer treatment. Improved surgical techniques and reconstruction methods enhance outcomes for locally advanced pelvic tumors.

More Related Videos

Laparoscopic Non-Mesh Cerclage Pectopexy for Pelvic Organ Prolapse
03:43

Laparoscopic Non-Mesh Cerclage Pectopexy for Pelvic Organ Prolapse

Published on: September 13, 2022

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

Related Experiment Videos

Last Updated: May 26, 2026

Laparoscopic Non-Mesh Cerclage Pectopexy with Uterine Preservation for Pelvic Organ Prolapse
03:30

Laparoscopic Non-Mesh Cerclage Pectopexy with Uterine Preservation for Pelvic Organ Prolapse

Published on: October 25, 2024

Laparoscopic Non-Mesh Cerclage Pectopexy for Pelvic Organ Prolapse
03:43

Laparoscopic Non-Mesh Cerclage Pectopexy for Pelvic Organ Prolapse

Published on: September 13, 2022

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

Area of Science:

  • Oncology
  • Surgical Oncology
  • Radiotherapy

Context:

  • Improvements in chemo-radiotherapy have reduced the need for stringent patient selection for pelvic exenteration in locally advanced tumors.
  • Advanced imaging techniques enhance the preoperative definition of tumor extension, optimizing surgical resection strategies.
  • Innovations in hemostatic devices and surgical approaches, including latero-endopelvic resection and intraoperative radiotherapy, are refining surgical management.

Purpose:

  • To review current advancements and evolving criteria in pelvic exenteration for locally advanced pelvic tumors.
  • To highlight the importance of preoperative imaging, surgical techniques, and reconstruction in managing complex pelvic malignancies.

Summary:

  • Patient selection criteria for pelvic exenteration have broadened due to improved local tumor control with chemo-radiotherapy.
  • Preoperative imaging and innovative surgical techniques, including laparoscopic approaches for central tumors and latero-endopelvic resection, are crucial.
  • Reconstruction, utilizing pelvic filling, continent urinary diversions, and myocutaneous flaps, is vital for reducing complications and improving patient outcomes.
  • Pelvic isolated perfusion is emerging as a potential neoadjuvant treatment or alternative to exenteration.

Impact:

  • Enhanced surgical precision and reduced blood loss contribute to better patient safety during pelvic exenteration.
  • Optimized reconstruction techniques improve functional outcomes and patient quality of life, addressing body image concerns.
  • The evolution of treatment strategies, including neoadjuvant therapies, promises improved oncological control for advanced pelvic cancers.